This study is looking at how blood sugar levels change after a liver transplant, especially for people who have had high blood sugar in the hospital or have Type 2 Diabetes. It uses a device called Libre 3+ (a continuous glucose monitor or CGM) to track blood sugar. You would wear this device after leaving the hospital. The main goal is to see how much time your blood sugar stays within a healthy range over 28 days. The study is open to adults aged 18 and older who have had a liver transplant and a blood sugar reading over 180mg/dL while in the hospital. We are looking for 40 participants, and the current recruitment status is unclear.

Study design

This is an observational study involving 40 participants. It is a blinded study, meaning you won't see your glucose readings in real-time.

What's involved

You will wear a blinded Libre 3+ sensor after hospital discharge for up to 30 days. You may also be invited to wear additional sensors at 6 and 12 months.

Compensation

Not stated in the trial record.

Follow-up

Your blood sugar levels will be measured for 28 days after discharge. You may also be invited to wear sensors at 6 and 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.